PharVision Advisers’s Arcos Dorados Holdings ARCO Stock Holding History

PharVision Advisers’s Portfolio ARCO Stock Details ARCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$86.8K	Sell	10,765 -1,970	-15%	-$17K	1.64%	28
2026 Q1	$105K	Sell	12,735 -29,095	-70%	-$236K	1.07%	45
2025 Q4	$307K	Buy	41,830 +1,976	+5%	+$14.2K	0.16%	258
2025 Q3	$269K	Buy	+39,854	New	+$283K	0.15%	291
2025 Q1	–	Sell	-48,055	Closed	-$350K	–	280
2024 Q4	$350K	Buy	+48,055	New	+$412K	0.3%	106

Other funds holding ARCO

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

SGDR

SPX Gestao de Recursos Rio De Janeiro, Brazil $898M AUM 45.5% 1-Year Est. Return

MCM

Moerus Capital Management New York $224M AUM 42.2% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CCM

Causeway Capital Management Los Angeles, California $9.24B AUM 21.27% 1-Year Est. Return

PharVision Advisers's ARCO Position: Q2 2026 in Review

PharVision Advisers reduced its Arcos Dorados Holdings (ARCO) stake by 15% in Q2 2026, selling an estimated $17K and leaving 10,765 shares worth $86.8K. The position accounts for 1.64% of the portfolio, ranked #28.

PharVision Advisers first reported a position in ARCO in Q4 2024 and has held it in 5 quarters since. The position peaked at $350K in Q4 2024. 176 funds tracked by Wall St. Rank hold ARCO as of Q2 2026.

PharVision Advisers held 10,765 shares of Arcos Dorados Holdings worth $86.8K as of Q2 2026.
PharVision Advisers sold 1,970 Arcos Dorados Holdings shares in Q2 2026, an estimated $17K.
Arcos Dorados Holdings made up 1.64% of PharVision Advisers's portfolio in Q2 2026, its #28 holding.
PharVision Advisers first reported a position in Arcos Dorados Holdings in Q4 2024 and has held it in 5 quarters since.
PharVision Advisers's Arcos Dorados Holdings position peaked at $350K in Q4 2024.
176 funds tracked by Wall St. Rank held Arcos Dorados Holdings as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.